USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.

USPTO PatentsView assignee record - 10 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Wilmar ranks #27,827 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 18 technology areas.

#27,827
of 49,997 US assignees by volume
Top 39%
by Innovation Score (39.0/100)
15.0
avg claims per patent
-25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27827 · Foreign Corporation #27,827 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #27,827/49,997
  • PHOTO-FINISH Westrock Slatersville
  • CPC-FOCUS C12N · 18 areas
  • INNOV-THIN 39.0/100
  • CLAIMS-RICH 15.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -25% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Westrock Slatersville, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Wilmar

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Wilmar's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Wilmar's grants concentrate

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 70% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2015. By volume, Wilmar sits between Westrock Slatersville, LLC and Wuhan Lotus Cars Co., Ltd.

Wilmar's three-year grant acceleration

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Wilmar's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Wilmar holds 10 patents at rank #27,807, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Wilmar

By rank, the assignees closest to #27,807 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Wilmar's primary technology class.

Wilmar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201520182019202020232025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 10.0%
2018 2 20.0%
2019 1 10.0%
2020 1 10.0%
2023 2 20.0%
2025partial year 3 30.0%

Which technologies does Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. patent most?

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#27,827

of 49,997 tracked assignees

Innovation Score

39.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s patent record in context - here's where to go next.

  • Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 70% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #27,827 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Wilmar (SHANGHAI) Biotechnology Research & Development Center Co., Ltd. against Westrock Slatersville, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.